Newswise COVID Experts

Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 20-Mar-2024 4:00 PM EDT Released to reporters: 18-Mar-2024 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Mutations do not predict the severity of current variants of SARS-CoV-2
Released: 15-Mar-2024 12:05 PM EDT
Mutations do not predict the severity of current variants of SARS-CoV-2
University of North Carolina at Charlotte

New research from UNC Charlotte’s Center for Computational Intelligence to Predict Health and Environmental Risks has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations compared to previous variants.

1-Mar-2024 3:05 PM EST
New Study Reveals Covid-19 May Have Originated in a Lab
Society for Risk Analysis (SRA)

Research from the journal Risk Analysis, examined the likelihood of COVID-19 coming from an unnatural origin (i.e. from a laboratory.)

Not for public release

Embargo will expire: 14-Mar-2024 11:05 AM EDT Released to reporters: 14-Mar-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 11:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-Mar-2024 10:05 AM EDT
New bioengineered protein design shows promise in fighting COVID-19
NYU Tandon School of Engineering

In the wake of the COVID-19 pandemic, scientists have been racing to develop effective treatments and preventatives against the virus. A recent scientific breakthrough has emerged from the work of researchers aiming to combat SARS-CoV-2, the virus responsible for COVID-19.

   
Released: 14-Mar-2024 9:00 AM EDT
Breast Cancer Diagnoses Plummeted During First Year of Pandemic
American College of Surgeons (ACS)

There was a 15-20% decrease in newly diagnosed breast cancer cases reported to American College of Surgeons Commission on Cancer sites in 2020 compared to 2019.

Newswise: Long COVID patients report improvements following self-regulation therapy, study finds
Released: 13-Mar-2024 2:05 PM EDT
Long COVID patients report improvements following self-regulation therapy, study finds
University of California, Los Angeles (UCLA), Health Sciences

A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies.

Released: 13-Mar-2024 10:05 AM EDT
How Rutgers Health Mobilized to Fight Covid-19
Rutgers University-New Brunswick

Multiple schools made significant discoveries and provided much-needed care to New Jersey’s disparate communities.

Newswise: Study provides new insights into deadly acute respiratory distress syndrome (ARDS)
Released: 12-Mar-2024 7:00 AM EDT
Study provides new insights into deadly acute respiratory distress syndrome (ARDS)
University of Minnesota College of Science and Engineering

Researchers at the University of Minnesota Twin Cities may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory illnesses such as COVID-19 or pneumonia.



close
2.05095